Related Experiment Video
Updated: Dec 13, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Aggressive Pituitary Adenomas and Carcinomas
Mirela Diana Ilie1, Emmanuel Jouanneau2, Gérald Raverot3
1Endocrinology Department VI, "C.I.Parhon" National Institute of Endocrinology, 34-36 Aviatorilor Boulevard, Bucharest 011863, Romania. Electronic address: https://twitter.com/the_hormone_doc.
Aggressive pituitary tumors can metastasize, posing diagnostic and treatment challenges. This review addresses current management strategies and highlights unanswered questions in the European Society for Endocrinology guidelines.
Area of Science:
- Endocrinology
- Oncology
Background:
- Pituitary tumors can exhibit aggressive behavior and metastasis, which is difficult to predict.
- Current European Society for Endocrinology (ESE) guidelines offer management strategies for aggressive pituitary tumors and carcinomas.
- Data scarcity limits comprehensive guidance, leaving several clinical issues unaddressed.
Purpose of the Study:
- To present key clinical aspects of aggressive pituitary tumors and carcinomas.
- To discuss unanswered questions within the ESE guidelines for these rare tumors.
- To focus on diagnostic and therapeutic challenges in managing aggressive pituitary tumors.
Main Methods:
- Literature review of aggressive pituitary tumors and carcinomas.
- Analysis of current European Society for Endocrinology (ESE) guidelines.
- Identification of knowledge gaps and areas for future research.
Main Results:
- Aggressive pituitary tumors and carcinomas require specialized management approaches.
- Predicting tumor behavior and metastasis remains a significant clinical challenge.
- Unaddressed questions in ESE guidelines pertain to optimal diagnosis and treatment protocols.
Conclusions:
- Further research is needed to refine diagnostic criteria and treatment strategies for aggressive pituitary tumors.
- Addressing the limitations in current guidelines is crucial for improving patient outcomes.
- A collaborative approach is essential to overcome data scarcity in managing these rare malignancies.
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cancer
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...

